文献速递眼底病与葡萄膜炎

整合代谢组学、基因组学与疾病通路解析年龄相关性黄斑变性:EYE-RISK联盟研究

Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration: The EYE-RISK Consortium.
PubMed 文献 · Ophthalmology · 2020-06-14

该研究在5个欧洲队列的2267例AMD患者和4266名对照中开展迄今为止规模最大的代谢组关联分析,鉴定出60种与AMD显著相关的代谢物,并发现52个AMD相关遗传变异中有7个与34种代谢物相关,且57种代谢物与补体激活水平独立于AMD状态相关。

要点

  • 大型HDL亚类升高及VLDL、氨基酸和柠檬酸降低与AMD相关。
  • 脂代谢基因ABCA1、CETP、APOE、LIPC变异与大/特大HDL亚类代谢物强相关。
  • 多数AMD相关代谢物与全身补体激活水平独立相关。

核心结论

  • 脂蛋白水平与AMD相关遗传变异相关,必需氨基酸降低可能提示AMD中的营养缺乏。
  • 绝大多数AMD相关代谢物与全身补体激活水平强相关,且独立于AMD状态。
  • 主要AMD疾病通路间可能存在生物学交互,成功治疗AMD或需同时靶向多条通路。

研究设计与样本

  • 病例对照关联分析,纳入5个欧洲队列共2267例AMD患者和4266名对照。
  • 采用高通量质子核磁共振代谢组学平台,定量146项代谢物测量和79项衍生值。
  • 用单变量逻辑回归分析代谢组与AMD关联,用线性回归分析52个AMD相关遗传变异对代谢物的效应及代谢物与补体通路活性(C3d与C3比值)的关联。

主要发现

  • 鉴定出60种与AMD显著相关的代谢物,包括大和特大HDL亚类水平升高,VLDL、氨基酸和柠檬酸水平降低。
  • 52个AMD相关遗传变异中7个与34种已鉴定代谢物显著相关,最强关联见于脂代谢基因ABCA1、CETP、APOE和LIPC附近变异与大/特大HDL亚类代谢物。
  • 60种代谢物中57种与补体激活水平显著相关且独立于AMD状态,大/特大HDL升高及VLDL和氨基酸降低与补体激活增加相关。

临床怎么用

  • 可关注大/特大HDL升高及VLDL、氨基酸和柠檬酸降低等代谢物谱用于AMD风险分层研究。
  • 脂代谢基因变异与大/特大HDL亚类的关联提示脂代谢通路是AMD潜在干预靶点。
  • 多数AMD相关代谢物与全身补体激活独立相关,支持联合靶向代谢与补体通路的治疗策略探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The current study aimed to identify metabolites associated with age-related macular degeneration (AMD) by performing the largest metabolome association analysis in AMD to date, as well as aiming to determine the effect of AMD-associated genetic variants on metabolite levels and investigate associations between the identified metabolites and activity of the complement system, one of the main AMD-associated disease pathways. DESIGN: Case-control association analysis of metabolomics data. PARTICIPANTS: Five European cohorts consisting of 2267 AMD patients and 4266 control participants. METHODS: Metabolomics was performed using a high-throughput proton nuclear magnetic resonance metabolomics platform, which allows quantification of 146 metabolite measurements and 79 derivative values. Metabolome-AMD associations were studied using univariate logistic regression analyses. The effect of 52 AMD-associated genetic variants on the identified metabolites was investigated using linear regression. In addition, associations between the identified metabolites and activity of the complement pathway (defined by the C3d-to-C3 ratio) were investigated using linear regression. MAIN OUTCOME MEASURES: Metabolites associated with AMD. RESULTS: We identified 60 metabolites that were associated significantly with AMD, including increased levels of large and extra-large high-density lipoprotein (HDL) subclasses and decreased levels of very low-density lipoprotein (VLDL), amino acids, and citrate. Of 52 AMD-associated genetic variants, 7 variants were associated significantly with 34 of the identified metabolites. The strongest associations were identified for genetic variants located in or near genes involved in lipid metabolism (ABCA1, CETP, APOE, and LIPC) with metabolites belonging to the large and extra-large HDL subclasses. Also, 57 of 60 metabolites were associated significantly with complement activation levels, independent of AMD status. Increased large and extra-large HDL levels and decreased VLDL and amino acid levels were associated with increased complement activation. CONCLUSIONS: Lipoprotein levels were associated with AMD-associated genetic variants, whereas decreased essential amino acids may point to nutritional deficiencies in AMD. We observed strong associations between the vast majority of the AMD-associated metabolites and systemic complement activation levels, independent of AMD status. This may indicate biological interactions between the main AMD disease pathways and suggests that multiple pathways may need to be targeted simultaneously for successful treatment of AMD.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Acar İE, Lores-Motta L, Colijn JM, et al. Integrating Metabolomics, Genomics, and Disease Pathways in Age-Related Macular Degeneration: The EYE-RISK Consortium. Ophthalmology. 2020. PMID: 32553749. doi:10.1016/j.ophtha.2020.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。